Evaluation of Primary Skin Irritation Safety of Curecode Double Barrier Cream in Humans

Skin Irritation Test of Curecode Double Barrier Cream

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011630

Enrollment

Registered

2026-02-23

Start date

2024-12-09

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others(Cosmetic product) : In this study, the cosmetic product “Curecode Double Barrier Cream” was applied to the backs of participants using a closed patch system for 24 hours. Skin reactions were ev

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Male or female adults aged between 20 and 60 years 2. Individuals with no dermatological disease or skin damage at the test site (back) 3. Individuals who voluntarily provided written informed consent after receiving sufficient explanation of the study 4. Individuals able to comply with the study procedures and visit schedule

Exclusion criteria

Exclusion criteria: 1. Individuals with dermatological disease, inflammation, wounds, or infection at the test site 2. Individuals who used topical products or medications that could affect study outcomes before or during the study 3. Individuals with a history of hypersensitivity or allergic reactions to cosmetics or test ingredients 4. Pregnant or breastfeeding women 5. Individuals deemed unsuitable for participation by the principal investigator

Design outcomes

Primary

Measure	Time frame
Occurrence of primary skin irritation and skin reaction score after application of the test product	—

Secondary

Measure	Time frame
Incidence of adverse events related to the test product during the study period	—

Countries

Korea, Republic of

Contacts

Public ContactMINYOUL CHANG

SKINMED

mychang195@gmail.com+82-42-5118-8437

Outcome results